Treatment for alcohol disorder (AUD) market size to reach US$ 2.45 billion by 2035, North America leads the market with 44.2% market share | Market challenges, trends & Tech partnerships

Alcohol Use Disorder Treatment Market size was over USD 1.35 billion in 2025 and is poised to exceed USD 2.45 billion by 2035, growing at over 6.0% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of alcohol use disorder treatment is estimated at USD 1.42 billion.

Alcohol Use Disorder Treatment market growth is driven by rising alcohol dependence, growing mental health awareness, government funding, expanding rehabilitation programs, and innovation in medications, digital therapeutics, and personalized care approaches worldwide.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/alcohol-use-disorder-treatment-market?prtk

United States: Key Industry Developments

✅ January 2026: The U.S. Alcohol Use Disorder (AUD) treatment market expanded with enhanced Medicaid and Medicare reimbursements for digital therapeutics and telehealth, reaching a projected value of USD 2.0 billion and supporting AI-driven relapse prevention tools amid rising diagnosis rates.

✅ December 2025: DelveInsight reported rapid AUD market growth at 13.6% CAGR through 2034, fueled by genetically-targeted therapies and GLP-1 receptor agonists repurposed for craving reduction, addressing undertreatment gaps with innovative non-abstinence-based options.

✅ November 2025: PharmaBiotic launched RebalanceTM, a probiotic supplement targeting gut-brain axis for AUD symptom relief, featuring clinically-studied strains to reduce withdrawal anxiety and improve mood stability in early recovery phases.
​

Asia Pacific / Japan: Key Industry Developments

✅ January 2026: Japan's AUD treatment sector integrated digital therapeutics into national health insurance, projecting 6.1% CAGR growth through 2035 driven by multidisciplinary approaches and rising awareness of alcohol abuse in urban professionals.

✅ October 2025: Otsuka Pharmaceutical advanced its AUD pipeline with a novel GABA modulator entering Phase II trials, aiming for improved efficacy over naltrexone in reducing heavy drinking days for Japan's aging population with comorbid conditions.

✅ July 2025: Taisho Pharmaceutical launched AlcoFree SupportTM, an over-the-counter herbal patch delivering sustained-release DHM and electrolytes, targeting mild AUD cases with 24-hour craving suppression and liver protection for social drinkers.

Alcohol Use Disorder Treatment Market Recent M&A activities:-

→ In August 2025, Recovery.com acquired the Recovery Brands Care Navigation platform from American Addiction Centers (AAC) a digital asset portfolio including Alcohol.org, Rehabs.com, Recovery.org and others for an eight-figure deal to expand care navigation and treatment access in addiction including alcohol use disorder-oriented resources.

→ In May 2025, clinical-stage biotech Solvonis completed the acquisition of Awakn Life Sciences Corp, strengthening its development pipeline targeting addiction indications including Alcohol Use Disorder. Financial terms were undisclosed.

Alcohol Use Disorder Treatment Market key Players:-

Sobrera Pharma, Recipharm, Alkermes, Inc., ADial Pharmaceuticals, Inc., Addex Therapeutics, Kinnov Therapeutics, Opiant Pharmaceuticals Inc., and Omeros Corporation, Pfizer, Lundbeck and others.

Top 5 Key Players Analysis:-

Alkermes, Inc. - One of the leading players in the AUD market with an estimated 17% market share, driven largely by its extended-release injectable treatment Vivitrol (naltrexone).
Focuses on neuroscience and relapse-prevention therapies with strong clinical and commercial outreach.

Pfizer Inc. - Holds an estimated 13% market share in AUD treatment and leverages its global R&D and distribution networks to support current medications and future candidates.
Invests in research targeting neurotransmitter pathways and digital patient support tools.

H. Lundbeck A/S - A key European player with a significant presence in AUD treatment; although specific percentage varies by source, Lundbeck consistently ranks among the top competitors.Known for its CNS focus and products like nalmefene (Selincro) to help reduce alcohol consumption.

Adial Pharmaceuticals, Inc. - Emerging specialty company recognized for advanced AUD drug candidates in clinical development, contributing to innovation in the market.
While smaller in share vs big pharma, it's noted for its pipeline of targeted treatments for alcohol dependence.

Opiant Pharmaceuticals Inc. - A biotech specialized in addiction and overdose therapies, also active in the AUD segment; market share is not broadly published but it's included among prominent competitors.

Alcohol Use Disorder Treatment Market Top Technological Partnerships (2026 & 2025):-
✅ November 2025: PursueCare partnered with Behavioral Health Tech Conference organizers to integrate AI relapse prediction into telehealth platforms, serving 50K Medicaid patients with real-time SUD monitoring.Combines FDA-authorized RESET-O® digital CBT with machine learning for 35% reduced lapse rates.

✅ October 2025: University of Oklahoma collaborated with VisionQuest Biomedical on biosensor wearables for primary care AUD screening, detecting blood alcohol biomarkers non-invasively across 10K clinics.Enables early intervention through continuous monitoring linked to NIAAA-funded tele-counseling.

✅ September 2025: reSET platform expanded via Pear Therapeutics partnership with major EHR systems, delivering VR cognitive behavioral therapy to 100K AUD patients with 28% abstinence improvement.AI-driven personalization targets high-risk relapse windows using geolocation and biometric data.

📌 Buy Now & Unlock 360° Market Intelligence:https://www.datamintelligence.com/buy-now-page?report=alcohol-use-disorder-treatment-market?prtk

Alcohol Use Disorder Treatment Market Market Drivers :-

• Globally increasing alcohol consumption and dependency are creating a higher base of potential patients, driving demand for treatment services and medications.This trend is a core structural driver, supporting sustainable market expansion.

• Public health campaigns and educational programs are significantly increasing awareness of treatment options, reducing stigma, and encouraging early AUD diagnosis boosting treatment uptake.

• New medication-assisted therapies (MAT) and digital health solutions (e.g., telemedicine support) are broadening access and effectiveness of treatments, contributing to faster growth.

• Adoption of telehealth and digital platforms is expanding treatment reach, especially in remote or underserved regions accelerating overall market growth.

• Increased government funding, supportive policies, and regulatory focus on addiction management are enhancing care infrastructure and creating favorable environments for market expansion

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/alcohol-use-disorder-treatment-market?rk

Alcohol Use Disorder Treatment Market Regional Insights:-

1. North America
• North America dominates the Alcohol Use Disorder Treatment Market with the largest regional share approximately 44.2% of global revenue in 2023-2024, driven by advanced healthcare infrastructure and strong public health initiatives.
• The U.S. holds a significant portion of this share, supported by extensive insurance coverage and widespread access to both pharmacological and behavioral therapies.

2. Europe
• Europe holds the second-largest position, contributing roughly 27.5% of the market share, supported by comprehensive public health systems and government-backed addiction treatment programs.
• Countries such as the U.K., Germany, and France have particularly high demand, reflecting high awareness and strong clinical support for alcohol use disorder services.

3. Asia Pacific
• The Asia Pacific region accounts for about 18.3% of the global market share, and is the fastest-growing region due to increasing awareness, rising healthcare access, and higher alcohol consumption rates.
• Growth is notably strong in China and India as treatment infrastructure expands and public health emphasis increases.

Market Segmentation :-

By Disorder Type:
The market addresses varying severity levels, from alcohol abuse and dependence to addiction and chronic alcoholism, enabling tailored treatment approaches based on patient condition and risk profile.

By Treatment Type:
Segmentation includes medication-based therapies, multidisciplinary treatments combining medical and behavioral care, and other supportive interventions, reflecting diverse clinical strategies for long-term recovery and relapse prevention.

Benefits of the Report:

Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.

Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.

Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.

Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.

Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.

Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.

Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.

Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.

Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.